T1	Participants 44 113	H5N1 subtype avian influenza virus recombinant protein-based vaccine.
T2	Participants 157 193	farmed poultry and free-living birds
T3	Participants 223 250	commercial chicken industry
T4	Participants 643 654	pBCX vector
